The use of clonazepam as an anticonvulsant--clinical evaluation.
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000927:Anticonvulsants / Q000008:administration & dosage / Q000009:adverse effects / Q000506:poisoning / Q000627:therapeutic use*; D001552:Benzazepines / Q000008:administration & dosage / Q000009:adverse effects / Q000506:poisoning / Q000627:therapeutic use*; D002648:Child; D002653:Child Behavior Disorders / Q000139:chemically induced; D002675:Child, Preschool; D004569:Electroencephalography; D004827:Epilepsy / Q000188:drug therapy*; D004832:Epilepsy, Absence / Q000188:drug therapy; D004833:Epilepsy, Temporal Lobe / Q000188:drug therapy; D004830:Epilepsy, Tonic-Clonic / Q000188:drug therapy; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D007659:Ketones / Q000627:therapeutic use; D008297:Male; D009574:Nitro Compounds / Q000627:therapeutic use; D012890:Sleep / Q000187:drug effects
D000927:Anticonvulsants; D001552:Benzazepines; D007659:Ketones; D009574:Nitro Compounds